• In the media
  • ‘Tekorten antibiotica gevolg van monopolie op...
Media - published on 01 Jun 2018

‘Tekorten antibiotica gevolg van monopolie op grondstoffen’, reports NOS

"More and more frequently occurring shortages of commonly used antibiotics are the result of monopolies or near-monopolies of the raw material producers" - Rinke van den Brink covers the Foundation's new white paper on antibiotic shortages.

Rinke van den Brink reports on the Foundation's new white paper about antibiotic shortages: "The increasingly frequent shortages of commonly used antibiotics are the result of monopolies or near-monopolies of the raw material producers ... According to Access to Medicine, pharmaceutical companies have little interest in to make the production and distribution chain for antibiotics more reliable. These are medicines that make relatively little money. They are cheap compared to many other means. Moreover, the demand is increasing in poor countries.

The white paper is titled 'Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role of pharmaceutical companies.' 


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.